Progentix BV

Progentix BV, founded in 2004, is a Dutch life sciences company that develops an innovative platform technology based on an automated, closed bioreactor system to expand bone marrow derived adult mesenchymal stem cells.

This expansion system is stand-alone, simple-to-operate and does not require a complex laboratory environment. It can be placed within any hospital department, and is able to generate over 200 million expanded adult stem cells.

Adult stem cells can be used in regenerative medicine to treat various tissue disorders (such as bone and cartilage defects, cardiovascular disease and central neural system disorders) and as a screening platform for the discovery of new drugs, small molecules and genes.

Progentix focuses on the clinical use of adult stem cells for bone regeneration and for that reason also develops a unique range of synthetic osteoinductive biomaterial scaffolds.